In 2025, the new domestic caprolactam capacity includes a 50,000-ton capacity expansion through technical renovation at Fujian Yongrong and a 600,000-ton new capacity addition at Guangxi Hengyi. Additionally, long-term idled units that have been shut down for over two years will be phased out, such as the 100,000-ton unit at Shijiazhuang Refining and Chemical and the 200,000-ton unit at Inner Mongolia Qinghua, totaling 300,000 tons.

PriceSeek's analysis of caprolactam gives a bullish/bearish score of -1. The article indicates that in 2025, domestic caprolactam will see a new capacity addition of 650,000 tons (50,000 tons from Fujian Yongrong and 600,000 tons from Guangxi Hengyi), while 300,000 tons of long-term idled units (100,000 tons from Shijiazhuang Refining and Chemical and 200,000 tons from Inner Mongolia Qinghua) will be phased out, resulting in a net capacity increase of 350,000 tons. The increase in supply may put downward pressure on spot prices, negatively impacting the market. A score of -1 indicates a generally bearish outlook, as capacity expansion directly increases supply, but no changes in demand are mentioned, resulting in a moderate impact.

For nylon POY, the bullish/bearish score is 1. Caprolactam is the main raw material for nylon POY, and its net capacity increase of 350,000 tons will reduce raw material costs, thereby lowering the production cost of nylon POY. The decrease in supply-side costs may benefit spot prices, especially in the context of stable or growing demand. A score of +1 indicates a generally bullish outlook, as cost reduction enhances profit margins, but changes in downstream textile demand should be monitored.

For nylon FDY, the bullish/bearish score is 1. As a type of nylon fiber, the production cost of nylon FDY is significantly affected by caprolactam prices. The net capacity increase of 350,000 tons in caprolactam is expected to lower raw material costs, reduce production barriers, and benefit nylon FDY spot prices. A score of +1 indicates a generally bullish outlook, as cost reduction may stimulate supply or support prices, but it should be evaluated in conjunction with downstream demand dynamics.

For nylon DTY, the bullish/bearish score is 1. The expansion of caprolactam capacity leads to an increase in raw material supply, and the decrease in costs will directly reduce the production cost of nylon DTY. This will help improve corporate profit margins and support spot prices when demand remains stable. A score of +1 indicates a generally bullish outlook, as improvements on the cost side bring positive effects, but actual market performance still needs to be observed in light of demand in the terminal textile industry.